Why This Matters
Ten years ago, early detection saved my life. I know what it means to catch breast cancer in time, and I know how many women aren’t so lucky. Too many high-risk women never learn their risk until it’s too late, simply because there’s no consistent standard for assessing it. The Know Your Risk Act would help change that. I’m asking you to act so that more women get the same second chance I did.
Breast cancer is the most commonly diagnosed cancer among American women aside from skin cancer, yet the risk assessment tools used to identify who is at elevated risk vary widely in accuracy and are inconsistently applied — leaving many high-risk women unaware of their status and without access to enhanced screening or preventive care.
H.R. 10763, the Know Your Risk Act (119th Congress), introduced in the U.S. House of Representatives, directs the Secretary of Health and Human Services (HHS) to evaluate existing breast cancer risk assessment tools, identify inaccuracies and gaps, and report findings to Congress, and to advance a single, standardized, publicly accessible risk assessment tool. Introduced by Rep. Julia Letlow (R-LA), the bill was inspired in part by the advocacy of actress and breast cancer survivor Olivia Munn, who is also working with Sen. Mark Kelly (D-AZ) on related Senate legislation to make lifetime risk assessments standard care. The bill also seeks to expand access to risk assessment services through the CDC’s National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which provides low-income and uninsured women with access to screening and diagnostic services. Standardizing and improving these tools could help ensure that more women — particularly those from underserved communities — receive timely, personalized guidance on their breast cancer risk.
Constituents are urged to call their U.S. Representatives to cosponsor and advance H.R. 10763 out of committee, and to call their U.S. Senators to introduce and champion a companion Senate bill. Broader adoption of evidence-based, standardized risk assessment tools is a critical step toward earlier detection, more equitable care, and ultimately fewer breast cancer deaths.